Cell Robotics' CEO Interviewed by the WallStreet Transcript About Diabetic Laser; CEO Also to be Interviewed by WallStreetNewsCast.Com.Business Editors & Health/Medical Writers ALBUQUERQUE, N.M.--(BW HealthWire)--May 2, 2000 Cell Robotics International, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CRII CRII Cooperative Research in Information Infrastructure CRII Customer Returns Improvement Initiative ), announced today that The WallStreet Transcript (TWST TWST The Wall Street Transcript (publication for professional investors) TWST Things We Said Today (band and a Beatles song) TWST Toronto Workshop on Software Testing ), a publication which interviews WallStreet professionals and corporate leaders, has published an interview with the Company's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Dr. Ronald K. Lohrding. In the interview, Lohrding discusses several key areas, including the Lasette(R), Cell Robotics' laser finger perforator per·fo·rate v. per·fo·rat·ed, per·fo·rat·ing, per·fo·rates v.tr. 1. To pierce, punch, or bore a hole or holes in; penetrate. 2. , which allows diabetics to sample their blood in a nearly painless way, reducing soreness, and eliminating the needle phobia phobia: see neurosis. phobia Extreme and irrational fear of a particular object, class of objects, or situation. A phobia is classified as a type of anxiety disorder (a neurosis), since anxiety is its chief symptom. problem for diabetics. The WallStreet Transcript Published Interview Commenting on future market opportunities during the interview, Lohrding stated, "Clearly, the single biggest market opportunity is in the personal laser finger perforator, which we call the Personal Lasette. We believe that this segment represents a multi-billion dollar market opportunity. Therefore, it's just a matter of accomplishing a small penetration rate to allow Cell Robotics to become a sizable company." For more of the interview, access The WallStreet Transcript's Web site at www.twst.com. The WallStreet Transcript (TWST) is a publication that has interviewed WallStreet professionals and corporate leaders for over 36 years. Its question and answer format has allowed readers to understand and interpret the meaning of an analyst's or CEO's comments for themselves. The WallStreet Transcript covers all the major market sectors with each new issue containing unique information that cannot be found anywhere else. The website can be accessed at www.twst.com. The WallStreet Newscast newscast Radio or television broadcast of news events. News gathering and broadcasting by the radio networks began in the mid-1930s and increased significantly during World War II. The television newscast began in 1948 with 15-minute programs that resembled movie newsreels. RealAudio Interview WallStreetNewsCast.Com will also interview Lohrding. The interview, to take place on Tuesday, May 2, 2000, will be made available later in the day and can be accessed at www.wallstreetnewscast.com. WallStreetNewsCast.Com specializes in bringing to the public RealAudio interviews with CEOs and their top management teams. About Cell Robotics International, Inc. Cell Robotics International, Inc. is a medical products company committed to enhancing the quality of life through technology. CRII manufactures, markets and distributes the Lasette(TM), the only FDA-cleared alternative to the needle or steel blade lancet currently available for diabetics to draw blood so as to test their glucose levels and an innovative scientific research instrument that uses laser light to transform a microscope from a viewing device into a tool for physically manipulating and dissecting dis·sect tr.v. dis·sect·ed, dis·sect·ing, dis·sects 1. To cut apart or separate (tissue), especially for anatomical study. 2. living cells in microspace. Additional information on all Cell Robotics' products is available on the Company's Web site at http://www.cellrobotics.com, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131. As a cautionary note to investors, certain matters discussed in this news release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; and the risks described from time to time in the Company's Securities and Exchange Commission filings. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion